Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers March 23, 2019
Pharmacy Choice - News - Over-the-Counter Drugs - March 23, 2019

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 130     Next >>     Go To Page:

3/14/19 - MIT - 'Inactive' ingredients may not be, study finds
While these components are usually considered benign, a new study from MIT and Brigham and Women's Hospital has found that nearly all pills and capsules contain some ingredients that can cause allergic reactions or irritations in certain patients. 'Right now there is an imbalance in the amount of information and understanding out there with respect
3/14/19 - Purchase of Non-Prescription Drugs Types of Medical Radiation Materials (Iobrix )
Address: Tel: +66-065-101010 ext. 7135. Description: Tenders are invited for Purchase of Non-Prescription Drugs Types of Medical Radiation Materials, Amount 2 Items. Tender for the Purchase of Non-Pharmaceutical Products Medical Radiation Material Type 2 Items with Electronic Tender Method Project Budget: 1,240,000.00 Project Status: In Process...
3/13/19 - Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) gets downgraded to Hold by Needham & Company LLC
Analyst Ratings For Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) Today, Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) stock was downgraded by Needham & Company LLC from Buy to Hold. There are 3 Hold Ratings, 2 Buy Ratings, no Strong Buy Ratings, no Sell Ratings on the stock. The current consensus rating on Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) i
3/13/19 - Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) gets downgraded to Hold by Needham & Company LLC with a price target of $22.20
Analyst Ratings For Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) Today, Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) stock was downgraded by Needham & Company LLC from Buy to Hold with a price target of $22.20. There are 3 Hold Ratings, 2 Buy Ratings, no Strong Buy Ratings, no Sell Ratings on the stock. The current consensus rating on Amphastar Pharm
3/13/19 - FDA Accepts Clinical Research Underlying GLUCODOWN Dietary Fiber Labeling
GLUCODOWN , manufactured by Glucose Health, Inc., is the leading functional tea beverage in the over-the-counter diabetic nutritional retail category, which encompasses the more than 100 million Americans estimated to be diabetic or pre-diabetic. 1 Food and Drug Administration regulations 2 enacted in 2016, provide that only forms of dietary fi
3/13/19 - Regeneron and Sanofi to Present New Praluent (alirocumab) Data at ACC.19
TARRYTOWN, N.Y. and BRIDGEWATER, N.J., March 13, 2019/ PRNewswire/. Regeneron Pharmaceuticals, Inc. and Sanofi today announced that four new sub-analyses from the Praluent ODYSSEY OUTCOMES cardiovascular outcomes trial will be presented at the American College of Cardiology's 68th Annual Scientific Session, held March 16-18, in New Orleans, LA
3/13/19 - Salix Announces Two Methylnaltrexone Poster Presentations for Opioid-Induced Constipation at the Annual Assembly of the American Academy of Hospice and Palliative Medicine and Hospice and Palliative Nurses Association
Salix Pharmaceuticals, one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal diseases, will present two posters at the Annual Assembly of the American Academy of Hospice and Palliative Medicine and Hospice and Palliative Nurses Association, being held in Orlando, Fla., Mar
3/13/19 - Southampton Memorial Detox Unit featured at EGCC Luncheon
Sonya L. Lee, Manager of Behavioral Health for the Detox Unit at Southampton Memorial Hospital in Franklin was the guest speaker for the standing-room only Feb. 21 Chamber of Commerce luncheon. After serving in the United States Navy for 27 years Dr. Lee retired in 2016 to pursue other endeavors. Southampton Memorial Hospital has launched a new 10
3/12/19 - FDA Approves Dupixent (dupilumab) for Moderate-to-severe Atopic Dermatitis in Adolescents
TARRYTOWN, N.Y. and CAMBRIDGE, Mass., March 12, 2019/ PRNewswire/ Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the U.S. Food and Drug Administration has approved Dupixent for adolescent patients 12 to 17 years of age with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescriptio
3/12/19 - Global Over the Counter (OTC) Drugs Market - Growth, Trends and Forecast (2019-2024)
The "Over the Counter Drugs Market- Growth, Trends, and Forecast" report has been added to ResearchAndMarkets.com' s offering. The global over the counter drugs market was valued at USD 303.51 billion in 2018, and it is estimated to be valued at USD 491.02 billion in 2024, witnessing a CAGR of 8.5%. The global over the counter drugs market is likel
3/12/19 - Global Over the Counter (OTC) Drugs Market - Growth, Trends and Forecast (2019-2024) - ResearchAndMarkets.com
The "Over the Counter Drugs Market- Growth, Trends, and Forecast" report has been added to ResearchAndMarkets.com' s offering. The global over the counter drugs market was valued at USD 303.51 billion in 2018, and it is estimated to be valued at USD 491.02 billion in 2024, witnessing a CAGR of 8.5%. The global over the counter drugs market is likel
3/12/19 - NSF International to Provide Pre-Assessment Audits to New GRMA Standards
NSF International issued the following news release:. -NSF International now providing interim gap audits to new GRMA standards while working toward accreditation to provide official GRMA certification for dietary supplements, cosmetics/personal care products and OTC drugs. NSF International, an independent public health and safety organization, is
3/12/19 - OTC Drugs: Worldwide Market Insights & Projections to 2024
The "Over the Counter Drugs Market- Growth, Trends, and Forecast" report has been added to ResearchAndMarkets.com' s offering. The global over the counter drugs market was valued at USD 303.51 billion in 2018, and it is estimated to be valued at USD 491.02 billion in 2024, witnessing a CAGR of 8.5%. The global over the counter drugs market is lik
3/12/19 - Secura Bio Acquires Global Rights To Farydak
HENDERSON, Nev. and SAN DIEGO, March 12, 2019/ PRNewswire/ Secura Bio, Inc., an integrated, commercial-stage biopharmaceutical company dedicated to the worldwide commercialization of significant oncology therapies, today announced that it has acquired the global rights to Farydak from Novartis. Multiple myeloma is a cancer that forms malignant
3/11/19 - Chi-Med Reports 2018 Full Year Results and Provides Updates on Key Clinical Programs
Fruquintinib Received New Drug Application approval for fruquintinib and launched in late November 2018 for colorectal cancer, the first ever China-discovered novel oncology drug to receive full NDA approval in China; and Completed an agreement with Eli Lilly and Company to amend the original 2013 license and collaboration agreement for fruquintini
3/11/19 - FDA approves Dupixent (dupilumab) for moderate-to-severe atopic dermatitis in adolescents
Today's approval expands the use of Dupixent in the U.S. to include both adults and adolescents with atopic dermatitis or moderate-to-severe asthma, "said George D. Yancopoulos, M.D., Ph.D., President and Chief Scientific Officer at Regeneron. "Given that Dupixent targets a key pathway in type 2 inflammation, we are also investigating it in a broa
3/11/19 - Global Thrombosis Drugs Market Forecast up to 2024: High Preference of Anticoagulant Drug Usage is Expected to Boost the Segment
North America is the major shareholder in the global thrombosis drugs market, followed by Europe. The availability of novel anticoagulants, the presence of dominant market players, increased disease awareness, and rising healthcare expenditure make North America a dominant shareholder in the market. Asia Pacific is the fastest growing region due to
3/11/19 - Novan Completes End-of-Phase 2 Meeting and Provides Additional Business Updates
Novan, Inc. today announced a number of recent business advancements. Novan concluded an end-of-Phase 2 meeting with the U.S. Food and Drug Administration regarding SB206 for the treatment of molluscum. PRIME is a scheme launched by the European Medicines Agency to enhance support for the development of medicines that target an unmet medical need
3/11/19 - Pharmaceutical Processing Seals: Global Market Outlook to 2023 - Increasing Demand for OTC Drugs is a Key Driver
The "Pharmaceutical Processing Seals Market by Material, Type, Application, and Region- Global Forecast to 2023" report has been added to ResearchAndMarkets.com' s offering. The pharmaceutical processing seals market is estimated to be USD 1.8 Billion in 2018 and is projected to reach USD 2.4 Billion by 2023, at a CAGR of 6%. North America is the m
3/11/19 - XARELTO (rivaroxaban) Significantly Reduced Ischemic Stroke in Patients with Nonvalvular Atrial Fibrillation in Large, Real-World Meta-Analysis of Non-Vitamin K Antagonist Oral Anticoagulants (NOACs)
The Janssen Pharmaceutical Companies of Johnson& Johnson today announced new results from a large, real-world meta-analysis of 95 studies investigating the use of non-vitamin K antagonist oral anticoagulants, including XARELTO , versus warfarin for stroke prevention in patients with nonvalvular atrial fibrillation. Results are now published in
3/10/19 - Another Opinion: An inept plan to fight drug addiction
New York does not levy sales tax on either over-the-counter or prescription medication, and it shouldn't. The law said the $100 million to be raised annually from manufacturers of opioids could not be passed on to consumers. It designated only $20 million of that $100 million to address drug addiction, with no plan for deploying it.
3/9/19 - Asthma Spacers Marketto Reach a Worth US$ 1,803.93 Mn by 2026
Albany, NY 03/09/2019 Asthma is a chronic respiratory condition that affects millions of people around the world. Aerosol drug delivery is the first line administration route in asthma management, and metered dose inhalers are the most common type of inhalers used in asthmatic conditions. The global Asthma Spacers Market was valued at US$ 1,3
3/9/19 - Postmortem Toxicology
Office Address: Department of Health and Human Services; Food and Drug Administration; Office of Acquisitions and Grants Services- Rockville; 4041 Powder Mill Road Beltsville MD 20705. Office of Acquisitions and Grants Services- Rockville. THE U.S. FOOD AND DRUG ADMINISTRATION is issuing this Sources Sought Synopsis as a means of conducting market
3/8/19 - Aequus Signs Term Sheet for Five Preservative Free Dry Eye Products
VANCOUVER- Aequus Pharmaceuticals Inc. is pleased to announce the signing of a term sheet for an exclusive license with Medicom Healthcare Ltd., a United Kingdom based pharmaceutical company with a focus on preservative free therapies in ophthalmology. Under the proposed license agreement, Aequus will receive commercial rights to Medicom's Evolve l
3/8/19 - Aequus Signs Term Sheet for Five Preservative Free Dry Eye Products [T-break Tech (Middle East)]
-Aequus Pharmaceuticals Inc. is pleased to announce the signing of a term sheet for an exclusive license with Medicom Healthcare Ltd., a United Kingdom based pharmaceutical company with a focus on preservative free therapies in ophthalmology. Under the proposed license agreement, Aequus will receive commercial rights to Medicoms Evolve line of...
Articles(s): 1 - 25 of 130     Next >>     Go To Page:


© 2019 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2019 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415